Amgen Got `Awesome Price' for Onyx: Brean's Mack

Amgen Got `Awesome Price' for Onyx: Brean's Mack Play

Aug. 26 (Bloomberg) -- Dr. Celine Gounder, a primary care physician, and Brean Capital's Gene Mack discuss Amgen's purchase of Onyx Pharmaceuticals. They speak with Carol Massar on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

  • On Air Now

    Street Smart with Trish Regan Watch Now

  • Next

    Taking Stock with Pimm Fox

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus